BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12242518)

  • 1. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton--biochemistry and cell biology of chondrosarcoma and its variants.
    Aigner T
    Virchows Arch; 2002 Sep; 441(3):219-30. PubMed ID: 12242518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histogenesis of the skeleton and morphogenesis of cartilage-forming neoplasias].
    Aigner T
    Verh Dtsch Ges Pathol; 2007; 91():49-56. PubMed ID: 18314595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias.
    Aigner T; Frischholz S; Dertinger S; Beier F; Girkontaité I; von der Mark K
    Histochem Cell Biol; 1997 Jun; 107(6):435-40. PubMed ID: 9243276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Matrix gene expression pattern as indicators of the biology of cartilage-forming tumors].
    Aigner T; Unni CC; Bjornsson J; Kirchner T
    Verh Dtsch Ges Pathol; 1998; 82():178-83. PubMed ID: 10095430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas.
    Aigner T; Müller S; Neureiter D; Illstrup DM; Kirchner T; Björnsson J
    Cancer; 2002 Apr; 94(8):2273-81. PubMed ID: 12001127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathomorphology of malignant chondrogenic bone tumors--an analysis of 94 cases from the Hamburg Bone Tumor Register (1974-1989)].
    Delling G; Welkerling H
    Z Orthop Ihre Grenzgeb; 1992; 130(1):1-8. PubMed ID: 1532267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoplastic chondroneogenesis as a characteristic of mesenchymal chondrosarcomas].
    Schörle CM; Unni KK; Aigner T
    Orthopade; 2002 Jun; 31(6):544-50. PubMed ID: 12149925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms.
    Aigner T; Dertinger S; Vornehm SI; Dudhia J; von der Mark K; Kirchner T
    Am J Pathol; 1997 Jun; 150(6):2133-41. PubMed ID: 9176404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histologic grading of chondrosarcoma. A qualitative and quantitative analysis of 74 cases of the Hamburg bone tumor register].
    Welkerling H; Werner M; Delling G
    Pathologe; 1996 Jan; 17(1):18-25. PubMed ID: 8685092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of bone tumors.
    Bertoni F; Bacchini P
    Eur J Radiol; 1998 May; 27 Suppl 1():S74-6. PubMed ID: 9652505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas.
    Aigner T; Loos S; Müller S; Sandell LJ; Unni KK; Kirchner T
    Am J Pathol; 2000 Apr; 156(4):1327-35. PubMed ID: 10751358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas.
    Dornauer K; Söder S; Inwards CY; Bovee JV; Aigner T
    Pathol Int; 2010 May; 60(5):365-72. PubMed ID: 20518886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
    Müller S; Söder S; Oliveira AM; Inwards CY; Aigner T
    Mod Pathol; 2005 Aug; 18(8):1088-94. PubMed ID: 15731776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
    Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
    Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
    Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
    Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondrocytic cell differentiation in clear cell chondrosarcoma.
    Aigner T; Dertinger S; Belke J; Kirchner T
    Hum Pathol; 1996 Dec; 27(12):1301-5. PubMed ID: 8958302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERG expression in chondrogenic bone and soft tissue tumours.
    Shon W; Folpe AL; Fritchie KJ
    J Clin Pathol; 2015 Feb; 68(2):125-9. PubMed ID: 25378537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma.
    Boeuf S; Kunz P; Hennig T; Lehner B; Hogendoorn P; Bovée J; Richter W
    J Pathol; 2008 Oct; 216(2):158-66. PubMed ID: 18702172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
    Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
    Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cartilaginous tumors of the skeleton].
    Meffert O; Peiper HJ
    Chirurg; 1976 Jul; 47(7):392-9. PubMed ID: 954515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.